Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate : GIMEMA CML Working Party analysis
収録刊行物
-
- J Clin Oncol.
-
J Clin Oncol. 28 2748-2754, 2010